Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Wendelin · SciRah

Researcher profile · Semantic Scholar

K. Wendelin

Share profile

K. Wendelin — researcher profile on SciRah

h-index: 11
Works: 36
Citations: 1,120

Most-cited papers

Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation.
N. Gokbuget, Daniel Stanze, J. Beck, H. Diedrich +16 more
2012Blood466 citations Open access
Semantic Scholar
Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
H. Wandt, K. Schaefer-Eckart, K. Wendelin, Bettina Pilz +16 more
2012The Lancet310 citations
Semantic Scholar
Moderate Intensive Chemotherapy Including CNS-Prophylaxis with Liposomal Cytarabine Is Feasible and effective in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Trial From the German Multicenter Study Group for Adult ALL (GMALL)
N. Goekbuget, J. Beck, M. Brueggemann, T. Burmeister +14 more
201269 citations
Semantic Scholar
Nilotinib (Tasigna®) and Low Intensity Chemotherapy for First-Line Treatment of Elderly Patients with BCR-ABL1-Positive Acute Lymphoblastic Leukemia: Final Results of a Prospective Multicenter Trial (EWALL-PH02)
O. Ottmann, H. Pfeifer, J. Cayuela, K. Spiekermann +21 more
2018Blood44 citations Open access
Semantic Scholar
Successful Subtype Oriented Treatment Strategies in Adult T-All; Results of 744 Patients Treated in Three Consecutive GMALL Studies.
D. Hoelzer, E. Thiel, R. Arnold, J. Beck +21 more
200936 citations
Semantic Scholar
First Results of the Risk-Adapted, MRD-Stratified GMALL Trial 08/2013 in 705 Adults with Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma (ALL/LBL)
N. Goekbuget, M. Stelljes, A. Viardot, K. Nachtkamp +22 more
2021Blood29 citations
Semantic Scholar
UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment
L. Bastian, A. Hartmann, T. Beder, S. Hänzelmann +24 more
2022Leukemia26 citations Open access
Semantic Scholar
Results of the Risk-Adapted, MRD-Stratified GMALL Trial 08/2013 in 281 T-ALL / T-Lbl Patients: Excellent Outcome of Standard Risk Thymic T-ALL
N. Goekbuget, W. Fiedler, N. Alakel, M. Topp +19 more
2022Blood15 citations Open access
Semantic Scholar
A Therapeutic Platelet Transfusion Strategy without Routine Prophylactic Transfusion Is Feasible and Safe and Reduces Platelet Transfusion Numbers Significantly: Preliminary Analysis of a Randomized Study in Patients after High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantat
H. Wandt, K. Wendelin, K. Schaefer-Eckart, M. Thalheimer +9 more
200815 citations
Semantic Scholar
Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia.
D. Beelen, R. Arnold, M. Stelljes, N. Alakel +20 more
2022Transplantation and Cellular Therapy12 citations Open access
Semantic Scholar
Spontaneous remission of acute lymphoblastic leukemia: A case report
Timm Höres, K. Wendelin, K. Schaefer-Eckart
2017Oncology Letters11 citations Open access
Semantic Scholar
Evaluation of Minimal Residual Disease (MRD) and MRD-Based Treatment Decisions in Ph/BCR-ABL Negative Adult Acute Lymphoblastic Leukemia (ALL): Experience from the German Multicenter Study Group for Adult ALL (GMALL)
N. Goekbuget, M. Brüggemann, J. Beck, C. Faul +15 more
201711 citations
Semantic Scholar
Long Term Follow-up of 121 Elderly Patients with Philadelphia-Positive Acute Lymphoblastic Leukaemia (Ph+ALL) Treated in Prospective GMALL Trials Supports a Greater Emphasis On Allogeneic SCT as Definitive Postremission Therapy.
H. Pfeifer, Christoph Wettner, B. Wassmann, A. Giagounidis +19 more
201211 citations
Semantic Scholar
Gemtuzumab Ozogamicin Plus Midostaurin in Combination with Standard Intensive Induction Therapy in Newly Diagnosed AML: Results from a Phase-I Study
C. Röllig, C. Schliemann, J. Mikesch, L. Fransecky +15 more
2021Blood10 citations
Semantic Scholar
Gemtuzumab ozogamicin plus midostaurin in combination with standard ‘7 + 3’ induction therapy in newly diagnosed AML: Results from the SAL‐MODULE phase I study
C. Röllig, C. Schliemann, L. Ruhnke, L. Fransecky +16 more
2024British Journal of Haematology9 citations Open access
Semantic Scholar
Interim Analysis of a Prospective Randomised Study Comparing a Therapeutic Platelet Transfusion Strategy with the Prophylactic Platelet Transfusion Standard in Patients after Autologous Peripheral Stem Cell Transplantation (ASCT).
K. Schaefer-Eckart, K. Wendelin, M. Wilhelm, U. Mahlknecht +4 more
20069 citations
Semantic Scholar
General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia
N. Gokbuget, K. Ihrig, M. Stadler, M. Stelljes +19 more
2023Haematologica7 citations Open access
Semantic Scholar
Interim Results of a Multicenter, Single-Arm Study to Assess Blinatumomab in Adult Patients (pts) with Minimal Residual Disease (MRD) of B-Precursor (BCP) Acute Lymphoblastic Leukemia (GMALL-MOLACT1-BLINA)
N. Goekbuget, Wiba Keke Wermann, S. Schwartz, A. Huettmann +20 more
20207 citations
Semantic Scholar
Clinical and genetic characterization of de novo double-hit B cell precursor leukemia/lymphoma
J. Stratmann, A. B. von Rose, Sebastian E. Koschade, K. Wendelin +9 more
2019Annals of Hematology6 citations
Semantic Scholar
Consolidation Therapy Is Associated with Significantly Lower Bleeding Risk Compared to Induction Therapy in Patients with Acute Myeloid Leukemia
K. Schaefer-Eckart, K. Wendelin, Bettina Pilz, M. Kramer +3 more
20146 citations
Semantic Scholar
Chemotherapy or Stem Cell Transplantation in Adult High Risk Ph/BCR::ABL1-Negative ALL Patients with Early MRD Negativity: Results of the Randomized GMALL Trial 08/2013
N. Goekbuget, Folker Schneller, K. Nachtkamp, J. Beck +19 more
2024Blood5 citations Open access
Semantic Scholar
Final analysis of the GMALL-PH-01 trial: phase II study of standard chemotherapy in combination with dasatinib in first line treatment of Philadelphia chromosome positive acute lymphoblastic leukemia
F. Lang, Andreas Voss, G. Kobbe, Christian Junghanss +13 more
2025Leukemia and Lymphoma2 citations Open access
Semantic Scholar
CNS Irradiation in Adult De Novo B-Precursor ALL / Lbl: Results of the Randomized GMALL T rial 08/2013 Indicate Potential Antileukemic Efficacy
N. Goekbuget, B. Steffen, K. Nachtkamp, B. Böll +20 more
2023Blood2 citations
Semantic Scholar
Early allogeneic stem cell transplantation after melphalan-induced aplasia leads to long-term survival in patients with primary refractory AML
Claudius Söhn, K. Schäfer-Eckart, K. Wendelin, Stefan Knop
2025Annals of Hematology1 citations Open access
Semantic Scholar
First clinical experience of isatuximab safety and tolerability in relapsed and refractory multiple myeloma: real-world data from a compassionate use program in Germany
T. Leitner, Cyrus Khandanpour, K. Wendelin, F. Oduncu +7 more
2024Frontiers in Hematology1 citations Open access
Semantic Scholar
Efficacy of imatinib maintenance after stem cell transplantation for Ph+/BCR::ABL1 positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease.
H. Pfeifer, W. Bethge, S. Schönland, Lisa Heberling +19 more
2026Leukemia and Lymphoma0 citations Open access
Semantic Scholar
POSTER: MPN-756: CPX-351 vs Standard of Care as Bridging to AlloHCT in Patients With Higher-Risk Myelodysplastic Neoplasms or Oligoblastic Acute Myeloid Leukemia: Results of the Randomized Phase 2 PALOMA Study
U. Platzbecker, M. Crysandt, Martin Kaufmann, A. Rank +32 more
2026Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
Early deep response to cilta-cel as 2nd CAR T-Cell therapy after CELMoD-based bridging for advanced multiple myeloma
Henrik Niklas, A. Bold, S. Völkl, Nicola Lang +5 more
2026Annals of Hematology0 citations Open access
Semantic Scholar
MPN-756: CPX-351 vs Standard of Care as Bridging to AlloHCT in Patients With Higher-Risk Myelodysplastic Neoplasms or Oligoblastic Acute Myeloid Leukemia: Results of the Randomized Phase 2 PALOMA Study
U. Platzbecker, M. Crysandt, Martin Kaufmann, A. Rank +32 more
2026Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
First promising results in younger adult patients (<65 yrs) with newly diagnosed ph/BCR::ABL positive ALL treated within the randomized GMALL evolve trial
F. Lang, H. Pfeifer, B. Böll, K. Wendelin +12 more
2025Blood0 citations Open access
Semantic Scholar
Impact of IKZFplus status and ABL1 kinase domain mutations in patients with newly diagnosed Philadelphia-chromosome positive acute lymphoblastic leukemia receiving imatinib and chemotherapy followed by allogeneic SCT within GMALL07/03
H. Pfeifer, M. Hanoun, Ahmet Elmaagacli, S. Raffel +18 more
2025Blood0 citations
Semantic Scholar
Outcome of Patients with Hematologic or Molecular Relapsed/Refractory (R/R) Acute T- Lymphoblastic Leukemia - Data from the GMALL Study Group
Anjali Cremer, M. Hanoun, R. Wäsch, S. Raffel +12 more
2024Blood0 citations
Semantic Scholar
Impact of Allogeneic Hematopoietic Cell Transplantation Post-Sars-Cov-2 Infection: A Retrospective Analysis By the German Cooperative Transplant Study Group
Osama Ahmad, J. Weller, N. Kroger, Eva-Maria Wagner Drouet +21 more
2024Blood0 citations
Semantic Scholar
S106: UBTF-ATXN7L3 GENE FUSION DUE TO 17Q21.31 DELETION DEFINES NOVEL HIGH-RISK ALL SUBTYPE AMENABLE TO MRD-BASED TREATMENT INTENSIFICATION
L. Bastian, A. Hartmann, T. Beder, S. Hänzelmann +24 more
2022HemaSphere0 citations Open access
Semantic Scholar
Immediate Allogeneic Hematopietic Stem Cell Transplantation for Patients with NPM1-Mutated AML in Molecular Relapse
K. Schaefer-Eckart, K. Wendelin, S. Dressler, Johannes Gärtner +2 more
2021Blood0 citations Open access
Semantic Scholar
Early Allogeneic Blood Stem Cell Transplantation after Melphalan-Induced Aplasia for Patients with Primary Refractory or Relapsed Acute Myeloid Leukemia - Results of a Retrospective Single Center Analysis
K. Schaefer-Eckart, K. Wendelin, S. Dressler, S. Martina +1 more
20160 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Viardot×16
Invite
A. Viardot — researcher profile on SciRah
H. Serve×14
Invite
H. Serve — researcher profile on SciRah
M. Brüggemann×12
Invite
M. Brüggemann — researcher profile on SciRah
N. Goekbuget×11
Invite
N. Goekbuget — researcher profile on SciRah

×10

Invite

M. Stelljes — researcher profile on SciRah

Invite

N. Gokbuget — researcher profile on SciRah

Invite

J. Beck — researcher profile on SciRah

Invite

D. Hoelzer — researcher profile on SciRah

Invite

S. Schwartz — researcher profile on SciRah

K. Schaefer-Eckart×7

Invite

K. Schaefer-Eckart — researcher profile on SciRah

Invite

M. Hanoun — researcher profile on SciRah

Invite

R. Wäsch — researcher profile on SciRah